A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of JNJ-54767414 (Daratumumab) in Healthy Participants
Clinical trial NCT03320707 · COMPLETED
Trial details
- NCT number
- NCT03320707
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-16
- Primary completion
- 2019-08-27
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.